• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Current Heart Failure Reports

    Current Heart Failure Reports

    JournalISSN 1546-9530eISSN 1546-9549中科院 医学 3区

    年发文量

    研究主题

    论文(968)

    排序
    1The Impact of Lifestyle Interventions and Mental Health Management on Arrhythmias in Heart Failure
    Jonathan P. Ariyaratnam,Adrian D. Elliott,Melissa E. Middeldorp,Prashanthan Sanders

    To summarise contemporary evidence on the impact of lifestyle interventions and mental health management on arrhythmias in patients with heart failure (HF), and to highlight emerging therapeutic opportunities. Lifestyle modification targets shared risk factors in both arrhythmias and HF. In atrial fibrillation (AF), weight loss, exercise, alcohol reduction, and risk factor management reduce arrhythmia burden and improve arrhythmia-related symptoms and quality of life. Similarly, in both HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF), exercise training improves functional capacity and quality of life, whilst dietary interventions and weight loss are particularly beneficial in HFpEF. Mental health disorders represent novel targets for intervention for arrhythmias in HF; these conditions are common in arrhythmia and HF patients and associated with poorer outcomes, but early data suggests that mental health interventions do not reduce arrhythmia burden or cardiovascular outcomes despite improving overall psychological well-being and quality of life. Lifestyle intervention to improve physical health is central to HF and arrhythmia care and established as a central pillar of management. Mental health represents an important but under-recognised target which requires urgent further investigation.

    2026
    引用
    AI阅读
    加入学术空间
    2Risk Prediction for Heart Failure in Patients with Cancer: Current Models and Future Directions
    Arianne Clare Agdamag, Alexandra S. Manaila-Nabi,Phoo Pwint Nandar,W. H. Wilson Tang

    Purpose of Review: Cancer survivors have an elevated risk for developing heart failure due to prior chemotherapy, radiation therapy, and other overlapping co-morbid conditions. With the advancement in cancer treatment, there is an increasing number of survivors who are at an even higher risk of developing heart failure. There is a growing need for heart failure specific risk prediction models in this population to facilitate early diagnosis and timely management. This review aims to summarize most recent findings on heart failure risk prediction among patients with history of cancer. Recent findings: Current risk prediction models focus on heart failure risk at the time of cancer treatment and shortly thereafter. There is limited data on heart failure risk among long term survivors. Central Figure: Approach in determining heart failure risk before, during, and, after cancer treatment

    2026
    引用
    AI阅读
    加入学术空间
    3Pharmacological Management of Atrial Fibrillation Across the Heart Failure Ejection Fraction Spectrum: Rate Control, Rhythm Control, and Beyond
    Giuseppe Barone,Luca Baldetti, Umberto Falanga,Matteo Pagnesi,Michiel Rienstra,Adriaan A. Voors,Marco Metra

    To summarise the contemporary pharmacological management of atrial fibrillation (AF) in heart failure (HF), focusing on rate and rhythm control and upstream therapies across the ejection fraction spectrum. Rate control remains a cornerstone of AF management, particularly in permanent AF or haemodynamically fragile patients, with beta-blockers, digoxin, and non-dihydropyridine calcium channel blockers selected according to ejection fraction phenotype. Concurrently, increasing evidence supports early rhythm-control strategies because of their prognostic benefits in HF populations, with current guidelines reinforcing a left ventricular ejection fraction (LVEF)-guided approach to antiarrhythmic drug selection. Beyond conventional drugs, HF guideline-directed medical therapy (GDMT) is emerging as an important upstream pharmacological strategy for modulation of the arrhythmogenic substrate. AF management in HF requires an integrated, phenotype-oriented approach combining symptom control, thromboembolic prevention, and optimisation of GDMT. LVEF remains a key determinant of pharmacological safety and therapeutic selection, whereas haemodynamic status primarily guides acute management decisions.

    2026
    引用
    AI阅读
    加入学术空间
    4Female Fingerprint: Sex-Specific Aspects in Patients with Atrial Fibrillation and Heart Failure
    Esther Roth,Laura Rottner

    Atrial fibrillation (AF) and heart failure (HF) frequently coexist and represent a major source of cardiovascular morbidity and mortality. This review summarizes current evidence on sex-specific differences in epidemiology, pathophysiology, clinical presentation, prognosis, and treatment in women with AF and HF. Emerging evidence indicates that women with AF and HF constitute a distinct clinical and biological phenotype. Women typically develop AF at older age, more commonly present with hypertension and HF with preserved ejection fraction (HFpEF), and report greater symptom burden and impaired quality of life. Sex-specific mechanisms including hormonal influences, atrial fibrosis, endothelial dysfunction, inflammation, autonomic dysregulation, and microvascular disease contribute to these differences. Population studies further demonstrate sex-related disparities in HF development and outcomes across AF subtypes. Despite increasing awareness, women remain underrepresented in clinical trials and are less likely to receive rhythm-control strategies, catheter ablation, or device therapy. Recognition of the “female fingerprint” in AF and HF is essential for individualized risk stratification and the advancement of precision cardiovascular medicine.

    2026
    引用
    AI阅读
    加入学术空间
    5Time to Storm the Next CASTLE: Can Atrial Fibrillation Ablation Improve Outcomes in Patients with Heart Failure and Preserved Ejection Fraction?
    Alex El Darzi,Maximilian Moersdorf, Michel Abou Khalil,Christian M Massad,Mohammad Montaser Atasi,Yara Menassa,Carlo El Khoury,Nassir F Marrouche

    Heart failure with preserved ejection fraction and atrial fibrillation frequently coexist and are linked by shared mechanisms including atrial myopathy, elevated filling pressures, fibrosis, and adverse hemodynamic interactions. The combination of both diseases worsens patient outcomes, and catheter ablation has emerged as a potentially important treatment strategy in this population. This review aims to summarize and highlight the current evidence on ablation in patients with atrial fibrillation and HFpEF. When examining outcomes of mortality, hospitalization, hemodynamics, and recurrence, ablation appears to be superior to medical treatment with some mixed results. However, no large trials have been conducted on the topic, and no clear guidelines for ablation in HFpEF patients exist. Ablation is promising but not yet definitive for patients with atrial fibrillation and HFpEF. Ongoing trials, including CASTLE-HFpEF should clarify the gaps including patient selection, procedural strategy, and outcome benefit.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 968 篇论文

    高被引作者

    作者引用发文
    Larry Allen18993
    Thomas M Maddox18681
    Vigen Rebecca18681
    Simrat Kaur8671
    Antoine Chaanine8671
    Ambarish Pandey8671
    Saurav Chopra8671
    Sunil K. Agarwal8671
    Batra Jaspreet8671
    Garg Aayushi8671

    高产作者

    作者引用发文
    Wai Hong Wilson Tang77929
    Javed Butler20514
    Grodin Justin L929
    Marat Fudim699
    Wilfried Mullens2408
    Tiny Jaarsma3327
    Pieter Martens1277
    Prithwish Banerjee406
    Mihai Gheorghiade1466
    R.A. De Boer5726

    相关期刊

    Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology
    Current opinion in cardiology
    Journal of Cardiology
    European heart journal supplements : journal of the European Society of Cardiology
    Expert review of cardiovascular therapy
    Heart failure clinics
    Archives of Cardiovascular Diseases
    Circulation: Heart Failure
    Korean circulation journal
    Cardiology Clinics